projectstartups.com
Quick Access:
Search VCs Search Startups Browse VCs Browse Startups Get VC Data Get Startup Data

NADMED

NADMED is a Finnish biotech company developing and commercializing a proprietary blood testing technology to measure all four forms of vitamin B3 (NADs) and glutathiones. This technology helps clinicians establish more precise and personalized treatments for various diseases by identifying imbalances in these crucial molecules linked to age-related health conditions. The company provides measuring kits and laboratory services for research, drug development, and clinical needs.

Funding Round:

Funding Amount: €3.5M

Date: 22-Aug-2024

Investors: Nordic Science Investments (NSI), Voima Ventures, University of Helsinki Funds, other private European investors, Business Finland

Markets: Biotech, Healthtech

HQ: Helsinki, Uusimaa, Finland

Founded: 2022

Website: https://www.nadmed.com/

LinkedIn: https://www.linkedin.com/company/nadmed

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/nadmed?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook:

Similar Startups

Invizius
Date: 24-Sep-2024
Markets: Biotech, Healthtech,...
HQ: Motherwell, North Lanarkshire,...
Prescriby
Date: 29-Apr-2024
Markets: Healthtech, Biotech
HQ: Reykjavík, Gullbringusysla,...
Sooma Medical
Date: 12-Mar-2024
Markets: Healthtech, Medical Devices,...
HQ: Helsinki, Uusimaa,...
CryoCloud
Date: 06-May-2025
Markets: Biotech, Healthtech,...
HQ: Utrecht, Utrecht,...
Pepticom
Date: 07-Jan-2025
Markets: Biotech, AI,...
HQ: Jerusalem, Israel
Promise Bio
Date: 16-Dec-2024
Markets: Healthtech, AI,...
HQ: Tel Aviv, Israel

Leave a Comment

    Quick Access:
    Search VCs Search Startups Browse VCs Browse Startups Get VC Data Get Startup Data

    Share this: